Studies on aducanumab were halted earlier this year because the drug didn't appear to be effective. But the new results suggest it's effective at a high dose, the Associated Press reported.
from WebMD Health webmd
Studies on aducanumab were halted earlier this year because the drug didn't appear to be effective. But the new results suggest it's effective at a high dose, the Associated Press reported.
